Amazon Pharmacy Introduces Automated Insulin Discounts

15-08-2023
PixelVortex
Amazon Pharmacy Introduces Automated Insulin Discounts
Amazon will provide eligible patients with immediate discounts on more than 15 insulin and diabetes care brands.
Gabby Jones/Bloomberg
Facebook Twitter

Amazon Pharmacy has announced a new initiative to automatically provide coupon discounts for insulin, aiming to expand access to affordable prices for this essential diabetes medication. Instead of requiring patients to manually enter a coupon code to avail of the reduced price of $35 per month, Amazon will now offer immediate discounts on over 15 insulin and diabetes care brands. This includes insulin vials, pens, continuous glucose monitors, and pumps.

Ad
  • Performance-Driven Digital Marketing
  • Google Ads Campaigns
  • SEO Optimization
  • Website Design & Development
  • Social Media Management
Boost Your Business

The high cost of insulin has long been a burden for the 40 million Americans with diabetes, prompting calls for greater affordability. Responding to pressure from President Joe Biden and US lawmakers, major insulin manufacturers such as Novo Nordisk, Eli Lilly, and Sanofi have already committed to reducing prices by up to 78% for some of their products.

The current cost of just three vials of certain types of insulin can exceed $1,000, and some patients require up to six vials per month. President Biden, in his State of the Union address earlier this year, pledged to extend the $35 cap on insulin expenses for seniors on Medicare to all patients through his Inflation Reduction Act.

While these price reductions are welcomed, it is worth noting that the 2021 law aimed at incentivizing companies to reduce prices may actually allow drug manufacturers to increase their profits. This is due to the removal of a cap on rebates, which means companies like Novo and Lilly could avoid paying significant rebates to Medicaid, the government's health program for low-income individuals.

With Amazon's automated insulin discounts, patients will now have easier access to affordable insulin and diabetes care products, helping to alleviate the financial burden associated with managing their condition. As efforts continue to expand access to lower-cost medications, it is hoped that more individuals will be able to afford the life-saving treatments they need.